best etfs australia 2 Are the ETPMPD and IJP ETFs Suitable for an ASX ETF Portfolio?

Are the ETPMPD and IJP ETFs Suitable for an ASX ETF Portfolio?

Investors looking to diversify their portfolio in 2024 may want to consider exploring the Global X Physical Palladium ETF (ASX: ETPMPD) and the iShares MSCI Japan ETF (ASX: IJP). These two ETFs offer exposure to different markets and have shown promising potential for growth.

The ETPMPD ETF provides investors with access to the precious metal of palladium, which has various industrial uses, especially in the automotive industry. With $8.23 million in funds under management, this ETF may still be considered relatively small. However, with effective marketing strategies and distribution to financial advisers, the ETF issuer may be able to grow its market cap and ensure sustainability in the long run.

On the other hand, the IJP ETF offers exposure to around 85% of the Japanese stock market at a low cost. With $417.48 million in funds under management as of July 2022, the IJP ETF has met the minimum criteria for total amount invested. Investors should take note of the 0.47% annual management fee charged by iShares for this ETF, which is below the average for all ETFs on the market.

Before making any investment decisions, investors are encouraged to conduct thorough research and compare the fees and costs of different ETFs. They can access free ETF reviews on both the ETPMPD and IJP ETFs on the Best ETFs Australia website to make informed investment choices. By staying informed and analyzing the potential growth opportunities of these ETFs, investors can make strategic decisions to enhance their portfolio performance in 2024.

Share this article
Shareable URL
Prev Post

Jodie Turner-Smith Shines in Stylish Sandals at ‘The Acolyte’ Premiere – Footwear News

Next Post

Russian and Chinese Influence Grows in Global Nuclear Energy Market

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
Subscribe to our newsletter
Stay informed on the latest market trends